Epigenetic-Mediated Dysfunction of the Bone Morphogenetic Protein Pathway Inhibits Differentiation of Glioblastoma-Initiating Cells
Jeongwu Lee(Cleveland Clinic Lerner College of Medicine), Howard A. Fine(Cornell University), Chui H. Cheng(National Institutes of Health), Misuk Kim(Samsung Medical Center), Qin Su, Mariam Totonchy(National Institutes of Health), Jennifer Walling(National Institutes of Health), Susie Ahn(National Institutes of Health), Kevin Woolard(National Institutes of Health), Thomas R. Cusack(Harvard University Press), Nicholas M. Donin(National Institutes of Health), Yuri Kotliarov(National Institutes of Health), Dragan Maric(National Institute of Neurological Disorders and Stroke), Svetlana Kotliarova(Georgetown University), Wei Zhang(Capital Medical University), Aiguo Li(National Institutes of Health), Hilary Ma(National Institutes of Health), Jean C. Zenklusen(National Cancer Institute), Chibawanye Ene(National Institutes of Health), Myung Jin Son(Korea Research Institute of Bioscience and Biotechnology)
Cited by 421
Related Papers
The chromatin accessibility landscape of primary human cancers
|Science|2018|1.3k
The Causes of Welfare State Expansion: Deindustrialization or Globalization?
|World Politics|2000|899
Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults
|Cancer|1993|864
Toward understanding and exploiting tumor heterogeneity
|Nature Medicine|2015|770
Stereotactic Radiosurgery for the Definitive, Noninvasive Treatment of Brain Metastases
|JNCI Journal of the National Cancer Institute|1995|584